'Podnosis': Sizing up data privacy legislation and what you missed from the Digital Pharma East conference
02 Nov 2022
Preview
Source: FierceHealthcare
Data privacy and the American Data Privacy and Protection Act take on new meaning after the Dobbs decision.
The American Data Privacy and Protection Act says it would protect “any information that describes or reveals the past, present or future physical health, mental health, disability, diagnosis or healthcare treatment of an individual.” The bill, introduced in July, comes at a time when more tech companies are breaking into the healthcare space and eyes are turning to the protection of reproductive health data. To gain insight into the bill’s uncertain future, Fierce’s Annie Burky spoke with Deven McGraw, lead of data stewardship and sharing at medical genetics company Invitae.
And listen in on a snippet from a panel senior editor Heather Landi moderated at Digital Pharma East on leveraging digital health tools and social determinants data to improve patients’ health.
To learn more about topics in this episode:
Post-Dobbs data privacy law in flux as experts, providers and tech companies rethink how to protect patient information
Post Dobbs fallout tracker—Nationwide legal abortions declined 6% from April to August, report estimates
Most physicians unclear on 'life-threatening emergencies' under abortion bans: survey
Deloitte: Health inequities cost industry $320B per year, signal unsustainable crisis
RISE 2022: Health plans grapple with how to acquire, implement health equity data
DarioHealth lands $30M deal with Sanofi to expand commercial reach of its digital therapeutics
Digital Pharma East
Podnosis is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Heather Landi and Paige Minemyer. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.